Diamyd Medical AB (publ) (OM: DMYD B)
Health Care · Biotechnology · SE
Skr0.90
-2.82% today · -90.6% 1Y
Public summary
A free snapshot of Diamyd Medical AB (publ), with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app Diamyd Medical AB (publ) (OM: DMYD B) operates in the Biotechnology industry within the Health Care sector. The company is valued at $13.74M.
Over the last twelve months the share price has lost 90.6%, trading between 0.90 and 17.88.
Tweenvest scores Diamyd Medical AB (publ) across four factors: quality 35/100, value 53/100, growth 53/100. Its strongest factor is value.
DMYD B price history
Key figures
- Market cap
- $13.74M
- Revenue (TTM)
- $49.79K
- P/E
- -0.50
- EPS
- -1.76
- Dividend yield
- —
- Beta (5Y)
- 2.14
- 52-week high
- Skr17.88
- 52-week low
- Skr0.90
- Avg volume (3M)
- —
- Shares outstanding
- 154.98M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shaperon Inc.KOSDAQ: A378800 | $13.98M | ₩2,020.00 | -1.94% |
| Kyntra Bio, Inc.NasdaqGS: KYNB | $13.93M | $3.44 | -4.18% |
| Inhibitor Therapeutics, Inc.OTCPK: INTI | $13.90M | $0.08 | +1.27% |
| Allarity Therapeutics, Inc.NasdaqCM: ALLR | $13.87M | $0.87 | +3.69% |
| Passage Bio, Inc.NasdaqCM: PASG | $13.68M | $4.25 | +5.99% |
| TaiwanJ Pharmaceuticals Co., Ltd.TPEX: 6549 | $13.56M | NT$5.94 | -4.19% |
| Akari Therapeutics, PlcNasdaqCM: AKTX | $13.03M | $5.70 | -12.44% |
| Pluri Inc.NasdaqCM: PLUR | $12.96M | $1.05 | -3.67% |